Brandon Calenda is a Cardiology physician. OpenAlex indexes 18 publications with 361 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
242 W Parkway
Pompton Plains, NJ 074441029
Telephone
973-831-7455Registry record last updated 24 Apr 2018.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20241 payment
- Novartis Pharmaceuticals CorporationProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.1%Beta blocker21.4%Metoprolol Succinate45%Metoprolol Tartrate22%Carvedilol12%Nebivolol Hcl8%Bisoprolol Fumarate7%Atenolol2%Labetalol Hcl2%Propranolol Hcl Er1%Sotalol1%Part D<11 patientsStatin15.6%Atorvastatin Calcium65%Rosuvastatin Calcium24%Pravastatin Sodium6%Simvastatin4%Part D≥232 patients+ 16 more classes in this area
Blood & clotting
17.7%Factor Xa inhibitor14.8%Eliquis76%Xarelto25%Part D≥184 patientsVitamin K antagonist1.4%Warfarin Sodium100%Part D≥26 patients+ 2 more classes in this area
Metabolism & gastrointestinal
1.1%Potassium supplement0.6%Potassium Chloride100%Part D≥13 patientsSGLT2 inhibitor0.4%Farxiga100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- ASYMPTOMATIC CORONARY ARTERIOVENOUS FISTULA: WHEN TO CLOSE?
Journal of the American College of Cardiology
2017 - Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy
Nature Reviews Cardiology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”